Bank of America Corp DE Invests $145.06 Million in DaVita Inc. $DVA

Key Points

• Bank of America acquired 651,999 DaVita shares worth approximately $145.1 million in the second quarter, representing about 1.02% of the company.
• Institutional investors and hedge funds own approximately 90.12% of DaVita. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $233.43.
• DaVita’s stock opened at $183.02 after declining 5.6%, while its latest quarterly results exceeded expectations: EPS was $4.02 versus the $3.88 estimate, and revenue rose 5.2% year over year to $3.55 billion.

Bank of America Corp DE acquired a new stake in shares of DaVita Inc. (NYSE:DVA - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 651,999 shares of the company's stock, valued at approximately $145,057,000. Bank of America Corp DE owned about 1.02% of DaVita as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in DVA. Fifth Third Bancorp lifted its position in DaVita by 831.4% in the first quarter. Fifth Third Bancorp now owns 38,411 shares of the company's stock worth $5,903,000 after purchasing an additional 34,287 shares during the period. Assenagon Asset Management S.A. increased its holdings in DaVita by 30.5% in the 2nd quarter. Assenagon Asset Management S.A. now owns 44,783 shares of the company's stock valued at $9,963,000 after buying an additional 10,477 shares during the period. SG Americas Securities LLC raised its stake in shares of DaVita by 27.4% in the 1st quarter. SG Americas Securities LLC now owns 212,293 shares of the company's stock valued at $32,627,000 after buying an additional 45,609 shares in the last quarter. Invst LLC acquired a new position in shares of DaVita in the 2nd quarter valued at $1,238,000. Finally, LSV Asset Management lifted its holdings in shares of DaVita by 1.1% during the 4th quarter. LSV Asset Management now owns 936,768 shares of the company's stock worth $106,426,000 after acquiring an additional 9,739 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DVA. UBS Group upped their target price on shares of DaVita from $235.00 to $270.00 and gave the company a "buy" rating in a research note on Friday, July 10th. Barclays lifted their price objective on DaVita from $218.00 to $224.00 and gave the company an "equal weight" rating in a report on Wednesday, August 5th. Zacks Research lowered DaVita from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 6th. Truist Financial dropped their target price on DaVita from $250.00 to $215.00 and set a "hold" rating for the company in a report on Friday, August 7th. Finally, Raymond James Financial set a $220.00 target price on DaVita in a research report on Friday, August 7th. Four research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $233.43.

DaVita Trading Down 5.6%

NYSE DVA opened at $183.02 on Friday. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $247.49. The company has a 50 day moving average of $200.58 and a 200-day moving average of $186.72. The firm has a market cap of $11.68 billion, a price-to-earnings ratio of 14.98, a PEG ratio of 0.50 and a beta of 0.83.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, topping analysts' consensus estimates of $3.88 by $0.14. The business had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.DaVita's revenue for the quarter was up 5.2% on a year-over-year basis. During the same period in the prior year, the company earned $2.95 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, analysts forecast that DaVita Inc. will post 14.57 earnings per share for the current year.

About DaVita

DaVita Inc NYSE: DVA is a healthcare company focused primarily on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis services for people with chronic kidney failure, including in-center hemodialysis and home-based dialysis options. Its services also include clinical care, education, nutrition support and other resources intended to help patients manage kidney disease.

DaVita also provides broader kidney-care services, including chronic kidney disease management, care coordination and support for patients who may be candidates for kidney transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.